Suvalent Therapeutics Inc.

Biotechnology company · Thousand Oaks, California, United States

Suvalent Therapeutics Inc. is a biotechnology company headquartered in Thousand Oaks, California, United States. It has received 4 US government small-business research awards (SBIR/STTR) from health agencies, $2.8 million in total, most recently in 2019.

Profile compiled from public records. Is this your company? Request a correction or update

Suvalent Therapeutics at a glance

Typebiotechnology company

HeadquartersThousand Oaks, California, United States

Employees (self-reported, 2019)7

What does Suvalent Therapeutics do?

US government research funding

4 SBIR/STTR small-business research awards from US health agencies, $2.8 million in total (2014 to 2019). NIH funding came from the National Cancer Institute.

Frequently asked questions about Suvalent Therapeutics

Where is Suvalent Therapeutics headquartered?

Suvalent Therapeutics Inc. is headquartered in Thousand Oaks, California, United States.

What does Suvalent Therapeutics do?

Suvalent Therapeutics Inc. is a biotechnology company.

Similar companies

Amgen IncThousand Oaks, California, United States
ADRX, Inc.Thousand Oaks, California, United States
Atara Biotherapeutics, Inc.Thousand Oaks, California, United States
LungLife AI, Inc.Thousand Oaks, California, United States
Proactive Diagnostics, Inc.Thousand Oaks, California, United States
Recursion PharmaceuticalsSalt Lake City, Utah, United States
Vericel CorpBurlington, Massachusetts, United States
SAB Biotherapeutics, Inc.Miami Beach, Florida, United States

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences